Cargando…
Therapeutic potential of TRPM8 channels in cancer treatment
Cancer is a multifactorial process associated with changes in signaling pathways leading to cell cycle variations and gene expression. The transient receptor potential melastatin 8 (TRPM8) channel is a non-selective cation channel expressed in neuronal and non-neuronal tissues, where it is involved...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073478/ https://www.ncbi.nlm.nih.gov/pubmed/37033630 http://dx.doi.org/10.3389/fphar.2023.1098448 |
_version_ | 1785019575405903872 |
---|---|
author | Ochoa, Sara V. Casas, Zulma Albarracín, Sonia L. Sutachan, Jhon Jairo Torres, Yolima P. |
author_facet | Ochoa, Sara V. Casas, Zulma Albarracín, Sonia L. Sutachan, Jhon Jairo Torres, Yolima P. |
author_sort | Ochoa, Sara V. |
collection | PubMed |
description | Cancer is a multifactorial process associated with changes in signaling pathways leading to cell cycle variations and gene expression. The transient receptor potential melastatin 8 (TRPM8) channel is a non-selective cation channel expressed in neuronal and non-neuronal tissues, where it is involved in several processes, including thermosensation, differentiation, and migration. Cancer is a multifactorial process associated with changes in signaling pathways leading to variations in cell cycle and gene expression. Interestingly, it has been shown that TRPM8 channels also participate in physiological processes related to cancer, such as proliferation, survival, and invasion. For instance, TRPM8 channels have an important role in the diagnosis, prognosis, and treatment of prostate cancer. In addition, it has been reported that TRPM8 channels are involved in the progress of pancreatic, breast, bladder, colon, gastric, and skin cancers, glioblastoma, and neuroblastoma. In this review, we summarize the current knowledge on the role of TRPM8 channels in cancer progression. We also discuss the therapeutic potential of TRPM8 in carcinogenesis, which has been proposed as a molecular target for cancer therapy. |
format | Online Article Text |
id | pubmed-10073478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100734782023-04-06 Therapeutic potential of TRPM8 channels in cancer treatment Ochoa, Sara V. Casas, Zulma Albarracín, Sonia L. Sutachan, Jhon Jairo Torres, Yolima P. Front Pharmacol Pharmacology Cancer is a multifactorial process associated with changes in signaling pathways leading to cell cycle variations and gene expression. The transient receptor potential melastatin 8 (TRPM8) channel is a non-selective cation channel expressed in neuronal and non-neuronal tissues, where it is involved in several processes, including thermosensation, differentiation, and migration. Cancer is a multifactorial process associated with changes in signaling pathways leading to variations in cell cycle and gene expression. Interestingly, it has been shown that TRPM8 channels also participate in physiological processes related to cancer, such as proliferation, survival, and invasion. For instance, TRPM8 channels have an important role in the diagnosis, prognosis, and treatment of prostate cancer. In addition, it has been reported that TRPM8 channels are involved in the progress of pancreatic, breast, bladder, colon, gastric, and skin cancers, glioblastoma, and neuroblastoma. In this review, we summarize the current knowledge on the role of TRPM8 channels in cancer progression. We also discuss the therapeutic potential of TRPM8 in carcinogenesis, which has been proposed as a molecular target for cancer therapy. Frontiers Media S.A. 2023-03-22 /pmc/articles/PMC10073478/ /pubmed/37033630 http://dx.doi.org/10.3389/fphar.2023.1098448 Text en Copyright © 2023 Ochoa, Casas, Albarracín, Sutachan and Torres. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Ochoa, Sara V. Casas, Zulma Albarracín, Sonia L. Sutachan, Jhon Jairo Torres, Yolima P. Therapeutic potential of TRPM8 channels in cancer treatment |
title | Therapeutic potential of TRPM8 channels in cancer treatment |
title_full | Therapeutic potential of TRPM8 channels in cancer treatment |
title_fullStr | Therapeutic potential of TRPM8 channels in cancer treatment |
title_full_unstemmed | Therapeutic potential of TRPM8 channels in cancer treatment |
title_short | Therapeutic potential of TRPM8 channels in cancer treatment |
title_sort | therapeutic potential of trpm8 channels in cancer treatment |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073478/ https://www.ncbi.nlm.nih.gov/pubmed/37033630 http://dx.doi.org/10.3389/fphar.2023.1098448 |
work_keys_str_mv | AT ochoasarav therapeuticpotentialoftrpm8channelsincancertreatment AT casaszulma therapeuticpotentialoftrpm8channelsincancertreatment AT albarracinsonial therapeuticpotentialoftrpm8channelsincancertreatment AT sutachanjhonjairo therapeuticpotentialoftrpm8channelsincancertreatment AT torresyolimap therapeuticpotentialoftrpm8channelsincancertreatment |